These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30030151)

  • 1. A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for Psoriasis.
    Foulkes AC; Watson DS; Carr DF; Kenny JG; Slidel T; Parslew R; Pirmohamed M; ; Anders S; Reynolds NJ; Griffiths CEM; Warren RB; Barnes MR
    J Invest Dermatol; 2019 Jan; 139(1):100-107. PubMed ID: 30030151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-TNF- αtreatment-related pathways and biomarkers revealed by transcriptome analysis in Chinese psoriasis patients.
    Liu L; Liu W; Zheng Y; Chen J; Zhou J; Dai H; Cai S; Liu J; Zheng M; Ren Y
    BMC Syst Biol; 2019 Apr; 13(Suppl 2):29. PubMed ID: 30953507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of biologic therapies in psoriasis vulgaris.
    Mala R; Fida M; Jorgaqi E; Vasili E
    Dermatol Ther; 2019 Jul; 32(4):e12936. PubMed ID: 30983095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Adherence to Biologic Agents in Psoriasis.
    Hsu DY; Gniadecki R
    Dermatology; 2016; 232(3):326-33. PubMed ID: 27093295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of antidrug antibodies correlates inversely with the plasma tumor necrosis factor (TNF)-α level and the efficacy of TNF-inhibitor therapy in psoriasis.
    Kui R; Gál B; Gaál M; Kiss M; Kemény L; Gyulai R
    J Dermatol; 2016 Sep; 43(9):1018-23. PubMed ID: 26892625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of etanercept combined plus methotrexate and comparison of expression of pro-inflammatory factors expression for the treatment of moderate-to-severe plaque psoriasis.
    Yu Q; Tong Y; Cui L; Zhang L; Gong Y; Diao H; Gao F; Shi Y
    Int Immunopharmacol; 2019 Aug; 73():442-450. PubMed ID: 31154289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of biologic therapies for plaque psoriasis.
    Ahn CS; Gustafson CJ; Sandoval LF; Davis SA; Feldman SR
    Am J Clin Dermatol; 2013 Aug; 14(4):315-26. PubMed ID: 23696234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms associated with etanercept response in moderate-to-severe plaque psoriasis.
    Ovejero-Benito MC; Prieto-Pérez R; Llamas-Velasco M; Belmonte C; Cabaleiro T; Román M; Ochoa D; Talegón M; Saiz-Rodríguez M; Daudén E; Abad-Santos F
    Pharmacogenomics; 2017 May; 18(7):631-638. PubMed ID: 28470127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meeting Report: Psoriasis Stratification to Optimize Relevant Therapy Showcase.
    Yiu ZZN; Barker JNWN; Barnes MR; Di Meglio P; Emsley R; Reynolds NJ; Smith CH; Warren RB; Griffiths CEM;
    J Invest Dermatol; 2021 Aug; 141(8):1872-1878. PubMed ID: 33771529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept and efalizumab for the treatment of psoriasis: a systematic review.
    Woolacott N; Hawkins N; Mason A; Kainth A; Khadjesari Z; Vergel YB; Misso K; Light K; Chalmers R; Sculpher M; Riemsma R
    Health Technol Assess; 2006 Nov; 10(46):1-233, i-iv. PubMed ID: 17083854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of pharmacogenomics upon the therapeutic response to etanercept in psoriasis and psoriatic arthritis.
    Murdaca G; Negrini S; Magnani O; Penza E; Pellecchio M; Puppo F
    Expert Opin Drug Saf; 2017 Oct; 16(10):1173-1179. PubMed ID: 28750567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network analysis of psoriasis reveals biological pathways and roles for coding and long non-coding RNAs.
    Ahn R; Gupta R; Lai K; Chopra N; Arron ST; Liao W
    BMC Genomics; 2016 Oct; 17(1):841. PubMed ID: 27793094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the psoriasis transcriptome across different studies by gene set enrichment analysis (GSEA).
    Suárez-Fariñas M; Lowes MA; Zaba LC; Krueger JG
    PLoS One; 2010 Apr; 5(4):e10247. PubMed ID: 20422035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
    Warren RB; Smith CH; Yiu ZZN; Ashcroft DM; Barker JNWN; Burden AD; Lunt M; McElhone K; Ormerod AD; Owen CM; Reynolds NJ; Griffiths CEM
    J Invest Dermatol; 2015 Nov; 135(11):2632-2640. PubMed ID: 26053050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological therapy induces expression changes in Notch pathway in psoriasis.
    Skarmoutsou E; Trovato C; Granata M; Rossi GA; Mosca A; Longo V; Gangemi P; Pettinato M; D'Amico F; Mazzarino MC
    Arch Dermatol Res; 2015 Dec; 307(10):863-73. PubMed ID: 26319047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of adalimumab in psoriatic patients previously treated with etanercept in a real-world setting.
    Fonseca E; Iglesias R; Paradela S; Fernández-Torres RM; Elberdín L
    J Dermatolog Treat; 2015 Jun; 26(3):217-22. PubMed ID: 24920071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etanercept provides a more physiological approach in the treatment of psoriasis.
    Altomare G; Ayala F; Berardesca E; Chimenti S; Giannetti A; Girolomoni G; Lotti T; Martini P; Peserico A; Guerra AP; Vena GA
    Dermatol Ther; 2008 Oct; 21 Suppl 2():S1-14. PubMed ID: 18837727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose Modification in Biologic Therapy for Moderate to Severe Psoriasis: A Descriptive Analysis in a Clinical Practice Setting.
    Baniandrés O; Rodríguez-Soria VJ; Romero-Jiménez RM; Suárez R
    Actas Dermosifiliogr; 2015 Sep; 106(7):569-77. PubMed ID: 25935194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of etanercept monotherapy for moderate-to-severe plaque psoriasis: A prospective 12-week follow-up study.
    Xie F; Wang R; Zhao ZG; Meng XF; Lin BW; Yang J; Wang WJ; Ding XY; Yang Y; Zhao H; Li CX; Li HJ; Zhou Y
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):943-947. PubMed ID: 29270758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.